Nutex Health NUTX Income Statement (2009-2026)

NASDAQ NUTX
$173.32 -0.35 (-0.20%)
As of: Nov 16, 2026 · 10:18 AM EST
Reported Financials

Nutex Health Quarterly Income Statement

Periods 71 quarters
Latest Sep 2026

Nutex Health reported revenue of $217.61M and net income of $57.34M for the quarter ended Sep 2026, down 18.7% year over year. This income statement covers 71 quarters of results from Mar 2009 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Income StatementIncome Statement Mar2009 Jun2009 Sep2009 Dec2009 Mar2010 Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Revenue & cost
Revenue
63.40M79.13M58.05M28.40M53.72M56.33M58.92M62.72M69.67M67.45M76.08M78.80M257.62M211.79M243.99M267.80M151.68M216.49M210.75M217.61M
Cost of RevenueCost of Rev
4.49M4.49M1.55M3.51M2.28M51.48M49.28M55.66M56.46M57.30M53.52M56.88M115.99M93.45M119.06M112.92M105.54M124.76M69.47M116.09M
Gross Profit
19.49M35.82M6.64M-23.71M0.53M4.85M9.65M7.07M13.21M10.16M22.56M21.92M141.63M118.34M124.92M154.88M46.14M91.73M141.28M101.53M
Operating items
Amortization - Intangibles
0.23M0.22M
Depreciation & Amortization - TotalDep. & Amort. (Tot)
Research & DevelopmentR&D
0.08M0.07M
Share-based Compensation (IS)Stock Comp.
0.05M0.08M0.05M1.90M0.25M0.05M0.64M0.05M-0.06M1.96M14.60M27.64M78.75M13.22M-2.60M-3.92M2.88M7.39M
Selling, General & AdministrativeSG&A
0.39M6.58M4.08M6.75M6.31M7.18M9.76M7.79M8.50M8.66M10.65M9.87M12.75M10.04M12.50M11.30M17.82M14.38M16.68M17.04M
Restructuring CostsRestructuring
3.60M3.89M0.01M0.04M536.00
Other Operating ExpensesOther Opex
6.27M6.13M8.28M7.69M8.83M8.44M7.24M9.54M5.19M9.47M7.50M6.42M7.77M11.04M11.61M11.96M10.20M13.28M14.98M14.23M
Operating ExpensesOpex
43.92M43.31M51.41M404.97M53.19M51.48M49.28M55.66M56.46M57.30M53.52M56.88M115.99M93.45M119.06M112.92M105.54M124.76M69.47M116.09M
Operating IncomeOp. Inc
15.54M29.24M-1.38M-428.68M-5.78M-4.45M-0.36M-0.82M-26.14M1.45M5.30M9.66M114.21M80.66M33.68M130.37M30.92M81.27M121.72M77.10M
Non-operating items
Non Operating Interest Expenses
1.94M1.86M4.37M3.40M2.86M3.14M4.84M4.10M4.24M4.44M5.05M5.38M5.05M6.12M5.68M5.45M4.98M4.68M4.67M4.86M
Goodwill impairment chargesGoodwill Impair.
398.14M3.20M
Gains (Losses) on Sale of Assets & InvestmentsGains on Sales
Interest & Investment IncomeInt & Inv Inc
288.00368.00
Other Non Operating IncomeOther Non Op Inc.
-0.24M-2.38M1.40M0.63M-0.21M-0.25M0.12M0.05M-0.33M0.24M0.60M-0.13M-0.04M-3.33M-4.27M-0.98M-0.05M-0.02M0.04M0.30M
Non Operating IncomeNon Op. Inc.
-2.47M-0.21M
Net income details
EBIT
15.54M29.24M-1.38M-428.68M-5.78M-4.45M-0.36M-0.82M-26.14M1.45M5.30M9.66M114.21M80.66M33.68M130.37M30.92M81.27M121.72M77.10M
EBT
13.35M25.00M-4.34M-431.45M-8.85M-7.83M-5.08M-4.87M-30.71M-0.15M3.90M-2.58M108.66M71.22M23.73M123.94M25.89M76.56M117.09M72.54M
Tax ProvisionsTaxes
-0.13M0.18M19.65M-8.54M1.81M-0.91M-0.82M-0.34M-3.00M0.39M0.89M4.59M8.61M20.41M7.59M27.14M9.29M13.80M20.77M15.20M
Income After Tax
13.47M24.83M-24.00M-422.91M-10.66M-6.92M-4.27M-4.52M-27.71M-0.54M3.01M-7.17M100.05M50.81M16.14M96.80M16.61M62.76M96.32M57.34M
Equity Income
Income from Continuing OperationsIncome (Continuing)
9.07M24.83M-24.00M-422.91M-10.66M-6.92M-4.27M-4.52M-27.71M-0.54M3.01M-7.17M100.05M50.81M16.14M96.80M16.61M62.76M96.32M57.34M
Income from Discontinued OperationsIncome (Discontinued)
Consolidated Net IncomeConsol Net Inc.
13.47M24.83M-24.00M-422.91M-10.66M-6.92M-4.27M-4.52M-27.71M-0.54M3.01M-7.17M99.97M50.81M16.14M96.80M16.61M62.76M96.32M57.34M
Net Income Attributable to Noncontrolling InterestsNCI Net Income
-0.50M3.38M-4.71M-10.72M4.09M-1.77M-0.79M1.02M3.91M-0.18M3.37M1.62M38.27M29.59M33.84M41.36M4.77M15.96M30.48M17.11M
Income towards Parent CompanyParent Net Inc
-22.46M21.44M-19.28M-412.19M-14.75M-5.15M-3.48M-5.54M-31.62M-0.36M-0.36M-8.79M61.70M21.22M-17.70M55.44M11.83M46.81M65.84M40.23M
Net Income towards Common StockholdersNet Income
-132.28M-16.76M-19.40M-422.52M-4.42M-5.15M-3.48M-5.54M-31.62M-0.36M-0.36M-8.79M61.70M14.96M-17.70M55.44M11.83M46.81M65.84M40.23M
Additional items
EPS (Basic)
-531.59-4.24-4.50-97.56-1.04-1.19-0.79-1.25-7.17-0.08-0.07-1.7212.122.71-2.958.271.866.709.585.87
EPS (Diluted)
-33.47-4.24-4.41-96.79-1.04-1.19-0.79-1.25-7.17-0.08-0.07-1.7211.482.56-2.957.721.756.529.385.71
Shares Outstanding
0.25M3.95M4.31M4.33M4.23M4.34M4.38M4.43M4.41M4.85M4.97M5.10M5.09M5.52M5.99M6.70M6.36M6.99M6.87M6.85M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
3.95M3.95M4.39M4.37M4.23M4.34M4.38M4.43M4.41M4.85M4.97M5.10M5.37M5.85M5.99M7.18M6.76M7.18M7.02M7.04M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
0.25M3.95M4.31M4.33M4.33M4.35M4.40M4.47M4.51M4.97M4.99M5.22M5.51M5.53M6.60M6.91M7.09M6.95M6.84M6.86M
EBITDA
17.57M31.86M1.75M-424.35M-2.51M-0.44M3.81M3.92M-21.46M5.64M9.83M14.64M119.49M85.75M38.93M135.37M36.11M86.76M127.04M82.72M
Interest ExpensesInt Expense
1.94M1.86M4.37M3.40M2.86M3.14M4.84M4.10M4.24M4.44M5.05M5.38M5.05M6.12M5.68M5.45M4.98M4.68M4.67M4.86M
Tax Rate
0.71%22.90%7.92%28.66%31.97%21.90%35.86%18.02%17.74%20.95%

Nutex Health Income Statement API

Pull Nutex Health's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=NUTX&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY